Herein, we prepared and characterized a novel biomimetic nanocapsule “NAcp@CD47”, which forms a thin polymer shell that can effectively penetrate the BBB and deliver encapsulated anti-CD47 antibodies and STING agonists in GBM to activate phagocytosis (Scheme 1). Here, CD47 is linked to glioblastoma.